Risk assessment as an evolved threat detection and analysis process

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 4, 2011, Pages 991-998

  Blanchard, D Caroline ^a   Griebel, Guy ^b   Pobbe, Roger ^c   Blanchard, Robert J ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b SANOFI   (France)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

Anxiety; Defensive behaviors; Fear; Human defenses; Mirror neurons; Risk assessment; Vigilance

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; RITANSERIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANXIETY; ANXIETY DISORDER; ASSOCIATION; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CELL FUNCTION; COGNITIVE DEFECT; DEFENSE MECHANISM; FEAR; GENERALIZED ANXIETY DISORDER; HAZARD; HUMAN; MICROBIOLOGY; MOTIVATION; MOTONEURON; NEUROPSYCHOLOGY; NONHUMAN; OLFACTORY DISCRIMINATION; PANIC; PERCEPTION; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RODENT; SOCIAL ENVIRONMENT; SPECIES DIFFERENCE; THREAT; TREATMENT RESPONSE; VISUAL DISCRIMINATION;

ADAPTATION, PSYCHOLOGICAL; AGONISTIC BEHAVIOR; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ESCAPE REACTION; HUMANS; NEURAL PATHWAYS; NEURONS; RISK ASSESSMENT; SOCIAL PERCEPTION;

EID: 79951579885     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.10.016     Document Type: Review

References (59)

1. Aldao A., Nolen-Hoeksema S., Schweizer S. Emotion-regulation strategies across psychopathology: a meta-analytic review. Clin. Psychol. Rev. 2010, 30:217-237.
2. APA Diagnostic and Statistical Manual of Mental Disorders-III 1980, American Psychiatric Association, Washington, D.C.
3. APA Diagnostic and Statistical Manual of Mental Disorders-IV-TR 2000, American Psychiatric Society, Washington, D.C.
4. Andrews P.W., Thomson J.A. The bright side of being blue: depression as an adaptation for analyzing complex problems. Psychol. Rev. 2009, 116:620-654.
5. Beck A.T. Depression: clinical, experimental and theoretical aspects 1967, Hoeber, New York.
6. Bell M.B.V., Radford A.N., Rose R., Wade H.M., Ridley A.R. The value of constant surveillance in a risky environment. Proc. Roy. Soc. Biol. Sci. Series B 2009, 276:2997-3005.
7. Bezchlibnyk-Butler K., Aleksic I., Kennedy S.H. Citalopram-a review of pharmacological and clinical effects. J. Psychiatry Neurosci. 2000, 25:241-254.
8. Blanchard D.C. Stimulus and environmental control of defensive behaviors. The Functional Behaviorism of Robert C. Bolles: Learning, Motivation and Cognition 1997, 283-305. American Psychological Association, Washington, D.C. M. Bouton, M. Fanselow (Eds.).
9. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 2001, 25:205-218.
10. Blanchard D.C., Hynd A.L., Minke K.A., Minemoto T., Blanchard R.J. Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neurosci. Biobehav. Rev. 2001, 25:761-770.
11. Blanchard D.C., Markham C., Yang M., Hubbard D., Madarang E., Blanchard R.J. Failure to produce conditioning with low-dose trimethylthiazoline or cat feces as unconditioned stimuli. Behav. Neurosci. 2003, 117:360-368.
12. Blanchard D.C., Blanchard R.J., Rodgers R.J. Risk assessment and animal models of anxiety. Animal Models in Psychopharmacology 1991, 117-134. Birkhauser Verlag AG, Basel. B. Olivier, J. Mos, J.L. Slangen (Eds.).
13. Blanchard R.J., Blanchard D.C. Anti-predator defensive behaviors in a visible burrow system. J. Comp. Psychol. 1989, 103:70-82.
14. Blanchard R.J., Blanchard D.C., Weiss S.M., Meyer S. The effects of ethanol and diazepam on reactions to predatory odors. Pharmacol. Biochem. Behav. 1990, 35:775-780.
15. Caggiano V., Fogassi L., Rizzolatti G., Thier P., Casile A. Mirror neurons differentially encode the peripersonal and extrapersonal space of monkeys. Science 2009, 324:403-406.
16. Canteras N.S. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol. Biochem. Behav. 2002, 71(3):481-491.
17. Carvalho-Netto E.F., Martinez R.C., Baldo M.V., Canteras N.S. Evidence for the thalamic targets of the medial hypothalamic defensive system mediating emotional memory to predatory threats. Neurobiol. Learn. Mem. 2010, 93:479-486.
18. Carvalho-Netto E.F., Nunes-de-Souza R.L. Use of the elevated T-maze to study anxiety in mice. Behav. Brain Res. 2004, 148:119-132.
19. Cezario A.F., Ribeiro-Barbosa E.R., Baldo M.V., Canteras N.S. Hypothalamic sites responding to predator threats-the role of the dorsal premammillary nucleus in unconditioned and conditioned antipredatory defensive behavior. Eur. J. Neurosci. 2008, 28:1003-1015.
20. Coss R.G., Owings D.H. Snake directed behavior by snake naïve and experienced California ground squirrels in a simulated burrow. Z. Tierpsychol. 1978, 48:421-435.
21. Deakin J.W., Graeff F.G. 5 -HT and mechanisms of defense. J. Psychopharmacol. 1991, 5:305-315.
22. Dielenberg R.A., McGregor I.S. Habituation of the hiding response to cat odor in rats (Rattus norvegicus). J. Comp. Psychol. 1999, 113:376-387.
23. Dielenberg R.A., Hunt G.E., McGregor I.S. "When a rat smells a cat": the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience. 2001, 104:1085-1097.
24. DiMicco J.A., Samuels B.C., Zaretskaia M.V., Zaretsky D.V. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol. Biochem. Behav. 2002, 71:469-480.
25. Ellard C.G., Eller M.C. Spatial cognition in the gerbil: computing optimal escape routes from visual threats. Anim. Cogn. 2009, 12:333-345.
26. Ellard C.G., Goodale M.A. A functional analysis of the collicular output pathways: a dissociation of deficits following lesions of the dorsal tegmental decussation and the ipsilateral collicular efferent bundle in the Mongolian gerbil. Exp. Brain Res. 1988, 71:307-319.
27. Fineberg N.A., Potenza M.N., Chamberlain S.R., Berlin H.A., Menzies L., Bechara A., Sahakian B.J., Robbins T.W., Bullmore E.T., Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010, 35(3):591-604.
28. Graeff F.G., Netto C.F., Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 1998, 23:237-246.
29. Griebel G., Blanchard D.C., Agnes R., Blanchard R.J. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute and chronic treatment with imipramine and fluoxetine. Psychopharmacology 1995, 120:57-66.
30. Griebel G., Perrault G., Sanger D.J. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berlin) 1998, 138:55-66.
31. Hadjikhani N., Joseph R.M., Snyder J., Tager-Flusberg H. Anatomical differences in the mirror neuron system and social cognition network in autism. Cereb. Cortex. 2006, 16:1276-1282.
32. Hilt L.M., Sander L.C., Nolen-Hoeksema S., Simen A.A. The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers. Neurosci. Lett. 2007, 429:12-16.
33. Hsu D.T., Price J.L. Midline and intralaminar thalamic connections with the orbital and medial prefrontal networks in macaque monkeys. J Comp. Neurol. 2007, 504:89-111.
34. Hsu D.T., Price J.L. Paraventricular thalamic nucleus: subcortical connections and innervation by serotonin, orexin, and corticotropin-releasing hormone in macaque monkeys. J. Comp. Neurol. 2009, 512:825-848.
35. Hubbard D.T., Blanchard D.C., Yang M., Markham C.M., Gervacio A., Chun I.L., Blanchard R.J. Development of defensive behavior and conditioning to cat odor in the rat. Physiol. Behav. 2004, 80(4):525-530.
36. Johnson M.R., Lydiard R.B., Ballenger J.C. Panic disorder, pathophysiology and drug treatment. Drugs 1995, 49:328-344.
37. LeDoux J. The amygdala. Curr. Biol. 2007, 17:R868-R874.
38. Litvin Y., Blanchard D.C., Blanchard R.J. Rat 22kHz ultrasonic vocalizations as alarm cries. Behav. Brain Res. 2006.
39. Marini G., Ceccarelli P., Mancia M. Characterization of the 7-12Hz EEG oscillations during immobile waking and REM sleep in behaving rats. Clin. Neurophysiol. 2008, 119:315-320.
40. Martin J.L., Sainz-Pardo M., Furukawa T.A., Martin-Sanchez E., Seoane T., Galan C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol. 2007, 21:774-782.
41. Martinez R.C., Carvalho-Netto E.F., Amaral V.C., Nunes-de-Souza R.L., Canteras N.S. Investigation of the hypothalamic defensive system in the mouse. Behav. Brain Res. 2008, 192:185-190.
42. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav. Rev. 2004, 28:285-305.
43. Mobbs D., Marchant J.L., Hassabis D., Seymour B., Tan G., Gray M., Petrovic P., Dolan R.J., Frith C.D. From threat to fear: the neural organization of defensive fear systems in humans. J. Neurosci. 2009, 29:12236-12243.
44. Mobbs D., Petrovic P., Marchant J.L., Hassabis D., Weiskopf N., Seymour B., Dolan R.J., Frith C.D. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007, 317:1079-1083.
45. Perkins A.M., Corr P.J. Reactions to threat and personality: psychometric differentiation of intensity and direction dimensions of human defensive behaviour. Behav. Brain Res. 2003, 169:21-28.
46. Perkins A.M., Ettinger U., Davis R., Foster R., Williams S.C., Corr P.J. Effects of Lorazepam and citalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety. J. Neurosci. 2009, 29:12617-12624.
47. Pinel J.P.J., Mana M.J. Adaptive interactions of rats with dangerous inanimate objects: Support for a cognitive theory of defensive behavior. Ethoexperimental Approaches to the Study of Behavior, NATO Advanced Science Institutes Series, Series D: Behavioural and Social Sciences 1989, vol. 48. Kluwer Academic/Plenum Publishers, New York, NY.
48. Pinheiro S.N., Del-Ben C.M., Zangrossi H., Graeff F.G. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. J. Psychopharmacol. 2008, 22:132-137.
49. Poltronieri S.C., Zangrossi H., de Barros Viana M. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav. Brain Res. 2003, 147:185-192.
50. Rizzolatti G., Fadiga L., Fogassi L., Gallese V. Resonance behaviors and mirror neurons. Arch. Ital. Biol. 1999, 137:85-100.
51. Rizzolatti G., Fadiga L., Gallese V., Fogassi L. Premotor cortex and the recognition of motor actions. Brain Res. Cogn. Brain Res. 1996, 3:131-141.
52. Shuhama R., Del-Ben C.M., Loureiro S.R., Graeff F.G. Defensive responses to threat scenarios in Brazilians reproduce the pattern of Hawaiian Americans and non-human mammals. Braz. J. Med. Biol. Res. 2008, 41:324-332.
53. Silveira M.C., Zangrossi H., de Barros Viana M., Silveira R., Graeff F.G. Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze. Behav Brain Res. 2001, 126:13-21.
54. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 2000, 65:571-576.
55. Takahashi L.K. Ontogeny of behavioral inhibition induced by unfamiliar adult male conspecifics in preweanling rats. Physiol. Behav. 1992, 52(3):493-498.
56. Wolpe J., Lang P.J. A fear survey schedule for use in behavior therapy. Behavior Modification Procedure: A Sourcebook 1974, Aldine Transaction, New Brunswick, NJ.
57. Yang M., Blanchard D.C., Augustsson H., Markham C.M., Hubbard D.T., Webster D., Wall P.M., Blanchard R.J. The rat-exposure test: behavioral characterization and strain comparison. Physiol. Behav. 2004, 81:465-473.
58. Ydenberg R.C., Dill L.M. The economics of fleeing from predators. Adv. Stud. Behav. 1986, 16:229-249.
59. Zamorski M.A., Albucher R.C. What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder. Am. Fam. Physician 2002, 66:1477-1484.